Source link : https://www.newshealth.biz/health-news/extended-results-confirm-standard-of-care-for-dlbcl/
SAN DIEGO — Patients with diffuse large B-cell lymphoma (DLBCL) continue to show superior progression-free survival at 5 years with first-line pola-R-CHP compared with the R-CHOP regimen, according to updated results of the phase 3 POLARIX study. These findings “confirm pola-R-CHP as the standard of care for patients with previously untreated intermediate- or high-risk DLBCL,” […]
Author : News Health
Publish date : 2024-12-10 11:21:29
Copyright for syndicated content belongs to the linked Source.